Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02673281 · ClinicalTrials.gov registry record · NA
Activation of Brain Centers by Short-term Walnut Consumption in Obesity
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02673281 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 10 participants.
The verdict
NCT02673281, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purposes of the study are: * Study Aim 1. To assess the mechanisms underlying the biological effects of short-term walnut consumption on appetite with functional magnetic resonance imaging (fMRI) and assessing neurocognitive function/memory * Study Aim 2. To investigate the effects of walnut consumption (48g per day over 5 days) on appetite and satiety by analyzing molecules which regulate energy homeostasis such as adipokines, as well as resting metabolic rate which measures energy expenditure. * Study Aim 3. To investigate the effects of walnuts (48g per day over 5 days) on insulin resistance, lipids, and inflammatory markers in obesity as well as the effect of walnuts when consumed as part of a mixed meal, on glucose excursions, insulin secretion and the excretion of gut peptides and free fatty acids.
Interventions
- OTHER Walnut shake
- OTHER Placebo shake
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-01 |
| Est. Completion | 2023-03-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02673281
The ClinicalTrials.gov registry entry for NCT02673281 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Walnut shake is the first listed.
NCT02673281 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02673281 about?
NCT02673281 is a clinical study titled "Activation of Brain Centers by Short-term Walnut Consumption in Obesity". The purposes of the study are: * Study Aim 1. To assess the mechanisms underlying the biological effects of short-term walnut consumption on appetite with functional magnetic resonance imaging (fMRI) and assessing neurocognitive function/memory * Study Aim 2. To investigate the effects of walnut co...
What is the current status of trial NCT02673281?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2016-01. Estimated completion is 2023-03-20.
What interventions are being tested in trial NCT02673281?
The interventions under investigation include: Walnut shake (OTHER), Placebo shake (OTHER).
Who is sponsoring clinical trial NCT02673281?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.